Your browser doesn't support javascript.
loading
Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy.
Dearden, Helen; Au, Lewis; Wang, Daniel Y; Zimmer, Lisa; Eroglu, Zeynep; Smith, Jessica L; Cuvietto, Marcello; Khoo, Chloe; Atkinson, Victoria; Lo, Serigne; Long, Georgina V; Sandhu, Shahneen; Ascierto, Paolo A; Carlino, Matteo S; Johnson, Douglas B; Larkin, James; Menzies, Alexander M.
Afiliação
  • Dearden H; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Au L; The Royal Marsden NHS Foundation Trust, London, UK.
  • Wang DY; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Zimmer L; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Eroglu Z; Moffitt Cancer Centre, Tampa, FL, USA.
  • Smith JL; Westmead Hospital, University of Sydney, Sydney, Australia.
  • Cuvietto M; Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli, Italy.
  • Khoo C; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Atkinson V; Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Australia; University of Queensland, Brisbane St Lucia, Queensland, Australia.
  • Lo S; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore Hospital and Mater Hospitals, Sydney, Australia.
  • Sandhu S; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Ascierto PA; Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli, Italy.
  • Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Westmead Hospital, University of Sydney, Sydney, Australia.
  • Johnson DB; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Larkin J; The Royal Marsden NHS Foundation Trust, London, UK.
  • Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore Hospital and Mater Hospitals, Sydney, Australia. Electronic address: alexander.menzies@sydney.edu.au.
Eur J Cancer ; 153: 168-178, 2021 08.
Article em En | MEDLINE | ID: mdl-34182268

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Anticorpos Monoclonais Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Anticorpos Monoclonais Idioma: En Ano de publicação: 2021 Tipo de documento: Article